Four Lp(a) lowering drugs are in clinical trials. They lower it by up to 94%.

Four Lp(a) lowering drugs are in clinical trials. They lower it by up to 94%.

Pelacarsen, olpasiran, lepodisiran, and muvalaplin are racing to become the first approved therapy for elevated Lp(a).

• Brandon Ballinger